Studies in Ethics Law and Technology · 2010 · 194 citations · 23 references
HumanitiesBioengineeringBiotechnologyEthicsNanobiotechnologyTechnology ForecastingMoral PhilosophyTechnology AssessmentBiotechnological EthicsDeliberationImpactsMoral DeliberationPolitical DeliberationScenario PlanningTechnological Ethics
Tools have been developed to anticipate future impacts of emerging technologies, yet most focus on hard, quantifiable effects while soft impacts such as changes to social roles, moral norms, and identities receive less attention. The authors argue that current assessment methods overlook the dynamic interplay between morality and technology, and propose a framework for scenarios that expand techno‑moral imagination. They develop a scenario‑building framework, illustrated with a biomedical nanotechnology example on human experimentation, and discuss its merits and limitations.
During the last decades several tools have been developed to anticipate the future impact of new and emerging technologies. Many of these focus on hard, quantifiable impacts, investigating how novel technologies may affect health, environment and safety. Much less attention is paid to what might be called soft impacts: the way technology influences, for example, the distribution of social roles and responsibilities, moral norms and values, or identities. Several types of technology assessment and of scenario studies can be used to anticipate such soft impacts. We argue, however, that these methods do not recognize the dynamic character of morality and its interaction with technology. As a result, they miss an important opportunity to broaden the scope of social and political deliberation on new and emerging technologies.In this paper we outline a framework for building scenarios that enhance the techno-moral imagination by anticipating how technology, morality and their interaction might evolve. To show what kind of product might result from this framework, a scenario is presented as an exemplar. This scenario focuses on developments in biomedical nanotechnology and the moral regime of experimenting with human beings. Finally, the merits and limitations of our framework and the resulting type of scenarios are discussed.
23
Gene expression profiling predicts clinical outcome of breast cancer
Laura van ‘t Veer, Hongyue Dai, Marc J. van de Vijver et al. · Nature · 2002 · 9.6K citations · Full text
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
Marc J. van de Vijver, Yudong D. He, Laura van ‘t Veer et al. · New England Journal of Medicine · 2002 · 6.5K citations · Full text
Medicine, Bioinformatics, Oncology +17
Philip W.F van Notten, M.B.A. van Asselt, Dale S. Rothman · Futures · 2003 · 676 citations